Akihiro Tsujimura
Chief Executive Officer chez MITSUBISHI TANABE PHARMA CORPORATION
Profil
Akihiro Tsujimura is currently the Co-Chief Executive Officer at Mitsubishi Tanabe Pharma Corp.
and the Chief Executive Officer & Director at SanBio, Inc. He was previously the President & Chief Executive Officer at Santen, Inc., Director & Senior Managing Executive Officer at Santen Pharmaceutical Co., Ltd., and Senior Managing Executive Officer at SanBio Co., Ltd.
Tsujimura holds an MBA from Kobe University and an undergraduate degree from Kanazawa University.
Postes actifs de Akihiro Tsujimura
| Sociétés | Poste | Début |
|---|---|---|
| MITSUBISHI TANABE PHARMA CORPORATION | Chief Executive Officer | - |
SanBio, Inc.
 SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA. | Chief Executive Officer | 01/10/2018 |
Anciens postes connus de Akihiro Tsujimura
| Sociétés | Poste | Fin |
|---|---|---|
Santen, Inc.
 Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a private company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Chief Executive Officer | 01/10/2018 |
| SANBIO COMPANY LIMITED | Chief Operating Officer | - |
| SANTEN PHARMACEUTICAL CO., LTD. | Director/Board Member | - |
Formation de Akihiro Tsujimura
| Kobe University | Masters Business Admin |
| Kanazawa University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SANTEN PHARMACEUTICAL CO., LTD. | Health Technology |
| SANBIO COMPANY LIMITED | Health Technology |
| Entreprise privées | 3 |
|---|---|
Mitsubishi Tanabe Pharma Corp.
 Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: OtherHealth Technology Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan. | Health Technology |
Santen, Inc.
Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a private company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Health Technology |
SanBio, Inc.
SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA. | Health Services |
